Valion Bio, Inc. Shareholders' Equity
Valion Bio, Inc. (VBIO) had Shareholders' Equity of $4.25 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.25M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $11.06M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $16.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.41M; Stockholders' Equity Attributable to Parent as first filed $5.59M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $4.25M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.06M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $16.80M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.41M 10-K · filed 2026-03-30 | $5.59M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $3.69M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $3.04M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $2.54M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $2.83M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $4.19M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $2.15M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $3.58M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $5.76M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.16M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $5.21M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $3.63M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $5.77M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $8.19M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $11.09M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $13.27M 10-K · filed 2024-03-25 | |
| 2021-09-30 | -$5.79M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$3.60M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$2.52M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$1.18M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |